I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something to compare against.
The narrow version of the question is what actually belongs on a baseline panel, as opposed to the enormous list that gets pasted around here.
Tell me what I have not thought of.
Taking the question as asked, rather than the general version of it. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
Dr.AddMedPHL said:The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.
No disagreement with Dr.AddMedPHL. One condition attached. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsDr.LipidDallas said:I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something…
This matches mine closely enough to be worth saying so. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.
That is the short version; the long version is somebody else's post.
Adding the clinical framing, because it changes how the question reads.
Blood work came back perfect. baseline bloodwork + this community = winning. 🏆